0001209191-17-050294.txt : 20170825
0001209191-17-050294.hdr.sgml : 20170825
20170825161705
ACCESSION NUMBER: 0001209191-17-050294
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170824
FILED AS OF DATE: 20170825
DATE AS OF CHANGE: 20170825
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NEWMAN MARY
CENTRAL INDEX KEY: 0001679132
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37833
FILM NUMBER: 171052162
MAIL ADDRESS:
STREET 1: C/O AUDENTES THERAPEUTICS, INC.
STREET 2: 101 MONTGOMERY ST., SUITE 2650
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Audentes Therapeutics, Inc.
CENTRAL INDEX KEY: 0001628738
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 461606174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 600 CALIFORNIA ST., 17TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94108
BUSINESS PHONE: 415-638-6556
MAIL ADDRESS:
STREET 1: 600 CALIFORNIA ST., 17TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94108
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-08-24
0
0001628738
Audentes Therapeutics, Inc.
BOLD
0001679132
NEWMAN MARY
C/O AUDENTES THERAPEUTICS, INC.
600 CALIFORNIA STREET, 17TH FLOOR
SAN FRANCISCO
CA
94108
0
1
0
0
SVP, Regulatory Affairs
Common Stock
2017-08-24
4
M
0
10000
2.19
A
10000
D
Common Stock
2017-08-24
4
S
0
10000
20.00
D
0
D
Stock Option (right to buy)
2.19
2017-08-24
4
M
0
10000
0.00
D
2025-02-04
Common Stock
10000
43817
D
This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
The option vested as to 25% of the total shares on October 1, 2015, and then 6.25% of the total shares vest quarterly thereafter, with 100% of the total shares vested and exercisable on October 1, 2018, subject to the reporting person's provision of service to the issuer on each vesting date.
/s/ Thomas Soloway as attorney-in-fact for Mary Newman
2017-08-25